tolbutamide has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YP; Dechon, J; Hu, G; Hu, J; Liu, Q; St John, PA; Suga, S; Takeo, T; Wakui, M; Wang, H; Wu, J; Yang, KC | 1 |
| Chang, Y; Li, GH; Lin, YF; Liu, Q; Mao, X; Misaki, N; Suga, S; Wakui, M; Wang, H; Wu, J | 1 |
2 other study(ies) available for tolbutamide and n-(1-methylethyl)-1,1,2-trimethylpropylamine
| Article | Year |
|---|---|
Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta.
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Humans; Membrane Potentials; Multidrug Resistance-Associated Proteins; Potassium Channels; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Rats, Wistar; Receptors, Drug; Rotenone; Substantia Nigra; Sulfonylurea Receptors; Tolbutamide | 2006 |
Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Diazoxide; Dose-Response Relationship, Drug; Female; Glucose; Humans; Insulin; Insulin-Secreting Cells; Ion Channel Gating; KATP Channels; Membrane Potentials; Nifedipine; Oocytes; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Tolbutamide; Xenopus laevis | 2007 |